Activation of Multiple Mitogen-Activated Protein Kinases in Pro/Pre–B Cells by GW7845, a Peroxisome Proliferator–Activated Receptor γ Agonist, and Their Contribution to GW7845-Induced Apoptosis
Open Access
- 3 May 2006
- journal article
- research article
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 92 (2) , 433-444
- https://doi.org/10.1093/toxsci/kfl003
Abstract
There is growing interest in using peroxisome proliferator–activated receptor (PPAR) γ agonists as chemotherapeutic agents in hematologic malignancies. PPARγ agonists of diverse chemical structure induce apoptosis in several malignant B cell lines. However, PPARγ agonists also induce apoptosis in normal B cells. One such agonist, GW7845, rapidly induces apoptosis in early B cells. Understanding the mechanisms of PPARγ agonist–induced death is essential to minimizing loss of normal cells during chemotherapy. PPARγ agonists influence mitogen-activated protein kinase (MAPK) cascades in other systems, and MAPKs can be associated with apoptosis. Therefore, we investigated the activation of MAPKs in primary pro–B cells and cultured pro/pre–B cells and their role in GW7845-induced apoptosis. Treatment of a nontransformed murine pro/pre–B-cell line with GW7845 transiently induced the phosphorylation of extracellular signal–related protein kinase (ERK) 1/2, but strongly and persistently induced the activation of p38 MAPK and c-Jun NH2-terminal kinase (JNK). In primary pro–B-cells, p38 MAPK and JNK were activated following treatment with GW7845. Phosphorylation of activating transcription factor-2 (ATF-2) was induced strongly in both B-cell types. In pro/pre–B cells, pretreatment with the p38 MAPK/JNK inhibitor PD169316 potently suppressed multiple facets of GW7845-induced apoptosis signaling. However, when a series of p38 MAPK and JNK inhibitors were used, only SB202190, also a dual inhibitor, completely suppressed GW7845-induced apoptosis. Inhibitors specific for p38 MAPK and JNK were only partially effective, suggesting that suppression of a single MAPK is not sufficient to inhibit death. The results support the hypothesis that GW7845 initiates an apoptotic pathway in early B cells through the activation of a kinase cascade that includes at least p38 MAPK and JNK.Keywords
This publication has 36 references indexed in Scilit:
- Environmental Chemical-Induced Bone Marrow B Cell Apoptosis: Death Receptor-Independent Activation of a Caspase-3 to Caspase-8 PathwayMolecular Pharmacology, 2005
- 2-Cyano-3,12-dioxoolean-1,9-dien-28-oic Acid and Related Compounds Inhibit Growth of Colon Cancer Cells through Peroxisome Proliferator-Activated Receptor γ-Dependent and -Independent PathwaysMolecular Pharmacology, 2005
- Nanomolar and Micromolar Effects of 15-Deoxy-Δ12,14-prostaglandin J2 on Amnion-Derived WISH Epithelial Cells: Differential Roles of Peroxisome Proliferator-Activated Receptors γ and δ and Nuclear Factor κBMolecular Pharmacology, 2005
- A Novel Ring-Substituted Diindolylmethane,1,1-Bis[3′-(5-Methoxyindolyl)]-1-(p-t-Butylphenyl) Methane, Inhibits Extracellular Signal-Regulated Kinase Activation and Induces Apoptosis in Acute Myelogenous LeukemiaCancer Research, 2005
- Peroxisome Proliferator-activated Receptor γ-independent Activation of p38 MAPK by Thiazolidinediones Involves Calcium/Calmodulin-dependent Protein Kinase II and Protein Kinase RJournal of Biological Chemistry, 2005
- p38α, but not p38β, inhibits the phosphorylation and presence of c-FLIPS in DISC to potentiate Fas-mediated caspase-8 activation and type I apoptotic signalingJournal of Cell Science, 2004
- Signalling pathways involved in multisite phosphorylation of the transcription factor ATF‐2FEBS Letters, 2004
- Mitogen-activated protein kinases in apoptosis regulationOncogene, 2004
- Peroxisome Proliferator-Activated Receptor-γ Activator 15-Deoxy-Δ12,14-Prostaglandin J2 Inhibits Neuroblastoma Cell Growth through Induction of Apoptosis: Association with Extracellular Signal-Regulated Kinase Signal PathwayThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Role of peroxisome proliferator-activated receptor-γ in hematologic malignanciesCurrent Opinion in Hematology, 2002